ROBERT W. GETTLEMAN, District Judge.
Plaintiff Magnetek, Inc. brought a three count complaint against defendants The Travelers Indemnity Company and Travelers Casualty and Surety Company (together "Travelers") seeking a declaration that defendants owe a duty to defend (Count I) and indemnify plaintiff (Count II) under certain insurance policies issued by defendants to plaintiff's predecessor. Count III is a claim for breach of contract. After the court denied Travelers' motion to dismiss for failure to name Velsicol Chemical LLC as a necessary party [Doc. 31], Travelers answered and filed a counter-claim, and Velsicol moved for and was granted leave to intervene as a defendant based on Travelers' assertion that Velsicol
This case presents a complicated background, made all the more complicated because none of the parties have bothered to include a narrative factual description of the case in their legal memoranda. Instead, the parties elected to rely on their Local Rule 56.1 Statements by incorporating them into their briefs. As this court has noted in the past,
The parties' failure to provide background sections in their briefs has left the court without a sufficient description of the underlying events leading to the contracts and documents on which plaintiff bases its claims and Travelers bases its defenses. The parties assume the court is as familiar as the parties with the underlying facts, jumping directly to their legal arguments without providing any context. "Rather than enlightening the court, the briefs have served only to confuse, focusing entirely on the narrow legal issues between the parties without providing sufficient background information to determine the import of those disputes."
In the late 1960s and early 1970s, Northwest Industries Inc. ("NWI") (later known as Fruit of the Loom ("FOTL") owned a company called Universal Manufacturing Corporation ("UMC"). UMC manufactured florescent light fixtures and ballast. UMC used polychlorinated biphenyls ("PCBs") in its products. It purchased the PCBs from Monsanto Company ("Monsanto"). Because of the environmental hazards posed by the use of PCBs, in 1972 Monsanto threatened to cut off UMCs supply unless UMC agreed to enter into a "Special Undertaking" in which UMC agreed to "defend, indemnify, and hold harmless Monsanto, its present, past and future directors, officers, employees and agents, from and against any and all liabilities, claims, damages, penalties, actions, suits, losses, costs and expenses arising out of or in connection with the receipt, purchase, possession, handling, use, sale or disposition of any such PCBs. . . ."
At least in part as a result of UMC entering the Special Undertaking, its parent, FOTL, purchased from Travelers several general liability insurance policies for itself and its subsidiaries, including UMC, which was a named insured on eight separate policies covering October 1, 1969 through October 1, 1970, October 1, 1970 through October 1,1973, October 1, 1969 through October 1, 1973, October 1, 1973 through October 1, 1974, October 1, 1974 through October 1, 1976, October 1, 1973 through October 1, 1976, October 1, 1976 through November 1, 1978 and October 1, 1976 through November 1, 1978.
In January 1986, FOTL sold UMC to plaintiff pursuant to a Stock Purchase Agreement ("SPA"). At the same time, those parties entered into a separate "Environmental Agreement" to deal with separate environmental matters, particularly with respect to environmental clean-up obligations at UMC's facilities.
In the following years, FOTL submitted numerous insurance claims to Travelers under the policies in question, arising out of both UMC's pre-sale activities, as well as claims on behalf of other named insureds. Many of the claims were disputed and resulted in litigation.
After the 1999 agreement, another dispute arose between Velsicol, FOTL and Travelers, this time dealing with certain "Asbestos Bodily Injury Claims" that had been brought against Velsicol. That dispute resulted in a lawsuit in the Circuit Court of Cook County entitled
Meanwhile, a number of claimants have filed lawsuits or otherwise asserted claims against Monsanto's successors and affiliates ("New Monsanto") alleging bodily injury and property damage caused by pollution from PCBs that Monsanto had manufactured back in the 1970s. On August 31, 2016, lawyers representing both New and Old Monsanto wrote to plaintiff demanding that plaintiff defend, indemnify, and hold harmless Old Monsanto in connection with all current and future PCB-related litigation in which Old Monsanto is or will be named as a defendant, and for the amount of any resulting judgments and settlements to the full extent required by the Special Undertaking. The letter formerly tendered the defense of a number of listed lawsuits. The letter indicated that Old Monsanto "would welcome the opportunity to discuss the PCB-related litigation . . . and the scope of [plaintiff's] obligations under the Special Undertaking." The letter further indicated that "New Monsanto expects to put a process in place for the resolution of this obligation, and those obligations of other similarly situated parties."
On September 7, 2016, plaintiff tendered notice of the Monsanto demand to Travelers and requested that Travelers defend and indemnify plaintiff under the applicable Travelers' policies. Travelers in turn, tendered plaintiff's demand to Velsicol pursuant to the 1999 and 2004 settlement agreements.
Neither Travelers nor Velsicol agreed to plaintiff's demands, so on April 27, 2017, plaintiff filed the instant action seeking defense and indemnity. In addition, to protect itself, two weeks after filing the instant action, plaintiff sued Monsanto in New Jersey (the "NJ Action") seeking a declaration that it has no duty to defend nor indemnify Monsanto in the underlying suits brought against Monsanto. Several months later, Monsanto responded by suing plaintiff in Missouri (the "Missouri Action") seeking a declaration that plaintiff owes it a duty to defend and indemnify.
Plaintiff and Travelers have filed cross-motions for summary judgment on plaintiff's claim in Count I that Travelers has a duty to defend plaintiff in the "underlying actions." Summary judgment is appropriate when the moving papers and affidavits show that there is no genuine issue as to any material fact and the movant is entitled to judgment as a matter of law. Fed. R. Civ. P. 56(a);
A genuine issue of material fact exists when "the evidence is such that a reasonable jury could return a verdict for the nonmoving party."
In the instant case there are few, if any, facts in dispute. The policies in question have been provided to the court, as have the SPA and the Environmental Agreement transferring UMC to plaintiff, as well as the settlements and release documents relied on by Travelers and Velsicol. The interpretation of an unambiguous contract is a question of law, and therefore a dispute over the terms of an unambiguous contract is suited to disposition on summary judgment.
Under Illinois law, an "insurer's duty to defend its insured is much broader than its duty to indemnify."
In its motion for summary judgment, plaintiff seeks a declaration that Travelers has a duty to defend plaintiff in what plaintiff calls the "Monsanto Litigation," consisting of plaintiff's suit against Monsanto in the New Jersey action and Monsanto's suit against plaintiff in the Missouri action. The parties appear to agree that the claims asserted in those actions, which ask those respective courts to decide whether plaintiff has a duty to defend or indemnify Monsanto in the "underlying actions," at least partially fall within the coverage provisions, because none of the parties have actually compared the Monsanto Litigation complaints to the policies' coverage provisions. Instead, the parties focus their arguments on the potential applicability of certain exclusions and other defenses.
Travelers' first argument is that the court should not even consider the Monsanto Litigation, or plaintiff's argument that the court should order Travelers to defend plaintiff in those cases, because neither of the cases had commenced when plaintiff brought the instant litigation, and neither of those cases is expressly referenced in the instant complaint.
In response, plaintiff first points out that the subject of the instant complaint was Monsanto's tender to and demand on plaintiff to at least participate in the defense of the underlying actions against Monsanto. The instant complaint specifically alleges that "Travelers owes [plaintiff] a duty to defend the claims by the Monsanto successors relating to the Underlying Actions as well as any other current or future PCB-related claims relating to or arising from occurrences during the Policy periods." It argues that the court can consider new legal arguments and matters on a motion for summary judgment, so long as the complaint's factual theory is not altered, and doing so would avoid unreasonable delay and minimize cost.
Travelers next argues that it has no duty to defend the underlying actions against Monsanto because plaintiff is not named in those suits and Monsanto is not a named insured under any of the policies. Travelers argues that what plaintiff is really seeking is not a defense, but rather reimbursement for anything it might ultimately be responsible for under the Special Undertaking. According to Travelers, this is not covered under the general liability provisions of the policies, but admits that it might be covered under the contractual liability provisions. In either event, Travelers argues that such a claim is for indemnity, not defense.
It is not entirely clear that plaintiff is asking the court to decide that Travelers must defend Monsanto in the underlying actions, but as plaintiff points out, each policy contains a contractual liability provision that provides (emphasis added):
In addition, the policies further provide that Travelers will defend any suit alleging such injury or damage and seeking damages payable under the terms of the policy. Thus, the contractual liability section of the policy also provides for defense of claims for which the insured is contractually liable.
Travelers next argues that by filing the New Jersey action, plaintiff violated its "duty to cooperate" under the policies. Each of the policies contains a clause similar or identical to the following:
According to Travelers, by filing the New Jersey action and starting the Monsanto Litigation, plaintiff assumed an obligation to defend at its own expense. As plaintiff points out, however, by the time it filed the New Jersey action, it had already tendered Monsanto's demand to Travelers, and Travelers had already rejected any responsibility under the policies to indemnify or defend. Thus, Travelers could not possibly be prejudiced by plaintiff's efforts to protect itself.
Finally, Velsicol argues that plaintiff is not entitled to summary judgment because it has failed to address Velsicol's affirmative defense based on the "Known Loss Doctrine." This doctrine provides that a risk is uninsurable if the insured knew or had reason to know when it purchased the policy that there was a substantial probability that it will suffer or already suffered a loss, because the risk ceases to be contingent and becomes a probable or known loss. Such a loss is uninsurable because the risk of liability is no longer unknown.
In the instant case, there is no evidence that FOTL (NWI) or even UMC knew, at the time the insurance was purchased, that Monsanto would be sued years later based on allegations that the PCBs that it sold to UMC would be released from UMC's final product, which is what the underlying actions against Monsanto allege. Nor could UMC (or plaintiff) have known that it would be sued for negligently releasing PCBs as Monsanto alleges against plaintiff. Thus, the court rejects Velsicol's argument that the Known Loss Doctrine applies.
That brings the court to Travelers' primary argument both in opposition to plaintiff's motion and in support of its own motion for summary judgment. According to Travelers, all of its obligations under the policies were released in the 2004 Settlement and Release Agreement. Additionally, it argues that under the terms of that agreement, all of the policies were deemed exhausted.
As noted above, Velsicol was an additional insured with its own separate policy limits under each of the policies in question. In 1999 Travelers, Velsicol and FOTL settled the coverage issues relating to the "Velsicol Environmental Claims," and in 2004 they settled their coverage issues relating to certain Asbestos Bodily Injury Claims that had been brought against Velsicol by entering into the Settlement and Release Agreement. The purpose and scope of that agreement was specifically stated as:
For purposes of the Agreement, FOTL was defined as FOTL Inc., and included a large number of related entities including "any Person insured by any of the Policies." Because UMC (now plaintiff) was a named insured, Travelers argues that any rights that UMC may have had under the policies were fully and finally released in the Agreement. In support of this argument, it cites a number of cases that, not surprisingly, hold that a parent that purchases insurance for its wholly owned subsidiary can release the subsidiary's rights under the insurance.
Similarly, Travelers argues that in the Settlement and Release Agreement, the parties deemed the policies exhausted. There is no doubt that parties to an insurance agreement can agree to exhaustion even if the policy is not actually exhausted by full payment of the policy limit. And, like a release, a parent can agree to deem a policy exhausted on behalf of its subsidiaries.
The problem with Traveler's argument is that at the time of execution of the 2004 Settlement and Release Agreement, FOTL no longer owned or controlled UMC (plaintiff), one of the named insureds, having sold it in 1986. Thus, absent something in the SPA or Environmental Agreement, FOTL had no authority to release UMC's rights under the policies. Travelers argues that a parent can agree to exhaust the policy to the detriment of a former subsidiary. It relies on
The settlement agreement in
That reasoning applies equally to the instant case, especially because the policies do not distinguish between the first named insured and other named insureds like UMC. Thus, the court concludes that absent a provision in the sale documents reserving that right to FTOL, it lacked authority to release UMC's rights.
Section 9.6(b) of the SPA provides that "Seller shall and hereby does, effective as of the Closing, transfer, assign, and convey to the Company [UMC] all rights of Seller against any insurer providing coverage under any such Insurance Policy with respect to any liability of any of the company or either Subsidiary. . . ." Thus, under the SPA, UMC's rights under the policies were "assigned" to UMC. Travelers argues that Section 6 of the Environmental Agreement pulled back those rights:
The Environmental Agreement, however, concerned environmental issues at UMC's plants and facilities, and covered costs of both compliance and clean-up obligations. It did not purport to deal with the types of claims presented in the instant case. Thus, the court concludes that Section 6 does not affect plaintiff's rights under the policies and further concludes that FOTL had no ability to release plaintiff's rights under the policies or to agree to deem the policies exhausted on plaintiff's behalf.
In its own motion for summary judgment, Travelers also argues that plaintiff released all of the rights that it claims it received under the UMC sale documents in a settlement agreement that it entered into in 2001 in the NWI/FOTL Bankruptcy Proceeding. In that release, the releasing parties agreed to release any claim "which any of the Releasing Parties ever had or may have against the Released Parties pursuant to the Magnetek agreements [including the UMC sale documents] and the Magnetek Judgment, and with respect to the matters addressed in the Magnetek agreement and Magnetek Judgment."
The court disagrees with Travelers' position that the 2001 settlement agreement between plaintiff and FTOL released any claims plaintiff may have against Travelers. A review of that agreement shows that it was intended to settle a dispute between plaintiff and FOTL over FOTL's refusal to pay the entirety of plaintiff's 1988 judgment against it. In particular, after paying a portion of the judgment, FOTL sued plaintiff for reimbursement of certain tax savings that plaintiff realized as a result of FOTL's payments under the SPA and judgment. The purpose of the settlement was to resolve that lawsuit and create a mechanism to share any tax savings. The release had nothing to do with any claims against Travelers under the insurance policies.
Next, Travelers argues that questions of facts exist as to the application of two of its affirmative defenses, requiring denial of plaintiff's motion. Once again, the court disagrees. First, Travelers argues that the "Pollution Exclusion" found in some, but not all, of the policies in question "has been found to apply in litigation between Travelers and FOTL regarding PCB contamination at and around UMC's former Bridgeport plant." The policy exclusion provides:
In
Travelers argues that the FOTL decision demonstrates that UMC understood and expected the hazards of PCB contamination. According to Travelers, this expectation creates a question of fact as to the application of the Pollution Exclusion. That FOTL decision, however, dealt with PBC spills and resulting contamination at the Bridgeport facility. The underlying cases brought against Monsanto assert bodily injury allegedly resulting from PCBs leaking from UMC's final product in numerous locations. Nothing in the FOTL decision suggests, in any way, that the exclusion should apply to the instant case. Certainly, its application is not "clear and free from doubt" given the claims in Monsanto Litigation and the claims brought against Monsanto. Provisions that limit or exclude coverage are to be construed strongly against the insurer and liberally in favor of the insured.
Travelers also argues that questions of fact exist as to whether any alleged bodily injury or property damage took place during the policy periods. This is a non-starter. That is one of the issues being litigated in the Monsanto Litigation that triggers the duty to defend. The underlying suits allege releases from UMC's final products. UMC purchased the PCBs and manufactured those products during the policy periods.
Consequently, for all the reasons discussed above, the court concludes that Travelers has a duty to defend plaintiff in the Monsanto Litigation. Ordinarily, under Illinois law, the duty to defend includes the right to control the defense to allow insurers to protect their financial interest in the outcome of the litigation and to limit or minimize unwarranted liability claims.
Such a nontrivial probability exists in the instant case. Monsanto has already suffered a $47,000,000 judgment, has settled another group of claims for $280,000,000 and faces additional lawsuits. It seeks indemnification from plaintiff for all amounts it has paid in connection with those claims. Plaintiff disputes that it could be held liable to Monsanto for those amounts, but the claims at issue in the Monsanto Litigation far exceed the policy limits. Consequently, the court concludes that plaintiff is entitled to control its defense.
For the reasons stated above, the court grants plaintiff's motion for partial summary judgment [Doc. 68] and denies Travelers' motion for summary judgment [Doc. 85]. The court thus holds that: (a) Travelers has a duty to defend plaintiff Magnetek in the Monsanto Litigation; (b) Magnatek may control its defense in that litigation; and (c) Travelers shall reimburse Magnetek for defense costs, past and future, in that litigation. The court also grants plaintiff's motion to file an amended complaint nunc pro tunc [Doc. 93].